✦ LIBER ✦

Hepatitis C virus kinetics in chimeric mice during antiviral therapy

✍ Scribed by Harel Dahari; Alan S. Perelson

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 63 KB
Volume: 46
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.21798

No coin nor oath required. For personal study only.

✦ Synopsis

Our data support the findings of Wieckowska et al. 2 in demonstrating that measuring serum CK-18 fragments level could potentially be used as a noninvasive diagnostic test to predict the severity of NAFLD; however, before the liver biopsy is abandoned altogether, verification of the noninvasive diagnostic in a bigger cohort of children is warranted.

📜 SIMILAR VOLUMES

Hepatitis C virus RNA kinetics in chimer

Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy

✍ Kazuaki Inoue; Tsunamasa Watanabe; Makoto Yoshiba; Michinori Kohara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Clearance kinetics of hepatitis C virus

Clearance kinetics of hepatitis C virus under different antiviral therapies

✍ Francesco Torre; Rosella Giusto; Alessandro Grasso; Renata Brizzolara; Nadia Cam 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Abstract Interferon alpha (IFN) has been the standard treatment for hepatitis C virus (HCV) infection. Using the kinetic curves of viral clearance, this study compared three treatment regimes based on IFN alone or in combination with Amantadine or Ribavirin to determine the mechanisms of action

Triphasic decline of hepatitis C virus R

Triphasic decline of hepatitis C virus RNA during antiviral therapy

✍ Harel Dahari; Ruy M. Ribeiro; Alan S. Perelson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

When patients chronically infected with hepatitis C virus (HCV) are placed on antiviral therapy with pegylated interferon (IFN)-␣ or IFN-␣ plus ribavirin (RBV), HCV RNA generally declines in a biphasic manner. However, a triphasic decline has been reported in a subset of patients. A triphasic declin

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: The null responder

✍ Adrian M. Di Bisceglie; Xiaofeng Fan; Thomas Chambers; Janice Strinko 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Our aim was to study the effect of ribavirin on viral kinetics and to study the early patterns of response to antiviral therapy of hepatitis C and their correlation with interferon pharmacokinetics and pharmacodynamics. We conducted a randomized, controlled trial of peginterferon alfa-2a with or wit

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Bernd Kronenberger; Eva Herrmann; Florence Micol; Michael von Wagner; Stefan Zeu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

Viral kinetics during antiviral therapy

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

✍ Claudio Puoti; Lia Bellis; Roberto Castellacci; Fabrizio Montagnese 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

We read with interest a paper by Kudo et al. published in a recent issue of HEPATOLOGY that compared the predictive power between Japan Integrated Staging (JIS) system and Cancer of the Liver Italian Program (CLIP) system in a large patient cohort with hepatocellular carcinoma (HCC). 1 The authors c